Latest News in the pharma Industry

Research & Development

Shift towards precision medicines forcing innovation in oncology drug development

Shift towards precision medicines forcing innovation in oncology drug development

26 Oct 2020

Webinar addresses key challenges in oncology drug development as a result of the shift towards precision medicines and the increasing use of biomarkers

Read more 
Vaccine manufacturing demand has had limited effect on regenerative medicine sector, panel tells CPhI audience

Vaccine manufacturing demand has had limited effect on regenerative medicine sector, panel tells CPhI audience

26 Oct 2020

The ramping up of vaccine manufacturing demand amid the COVID-19 pandemic had an initial impact on cell and gene therapy production but the regenerative medicine sector has largely weathered the storm, according to senior industry figures in a recent p...

Read more 
Sai Life Sciences to boost biology capabilities at its integrated R&D campus

Sai Life Sciences to boost biology capabilities at its integrated R&D campus

26 Oct 2020

The CRDMO will expand in vitro and in vivo biology services, DMPK and toxicology capabilities.

Read more 
RedHill Biopharma secures expanded manufacturing for COVID-19 therapeutic candidate

RedHill Biopharma secures expanded manufacturing for COVID-19 therapeutic candidate

20 Oct 2020

The biopharma company collaborates with European and Canadian suppliers for large-scale ramp-up of opaganib manufacturing.

Read more 
LLS Health signs partnership to develop one-year contraceptive vaginal system

LLS Health signs partnership to develop one-year contraceptive vaginal system

20 Oct 2020

The CDMO's Pathway TPUs are well-recognized as an effective option for many drug delivery systems.

Read more 
Streamlining biologics and biosimilars drug development process through a single source

Streamlining biologics and biosimilars drug development process through a single source

19 Oct 2020

The increasing number of complex and sensitive biologics and the administration shift from hospitals to patients' homes are two of today’s main biopharmaceutical industry challenges. Complex drugs and self-administration require an appropriat...

Read more 
Vaccine development toolkit needs to be optimized to counter infectious disease threat: CPhI webinar

Vaccine development toolkit needs to be optimized to counter infectious disease threat: CPhI webinar

13 Oct 2020

While there have been some huge advances in vaccine technology, more still needs to be done to counter the threat that infectious diseases pose, particularly to poorer countries.

Read more 
Cobra Biologics to manufacture plasmids for COVID-19 vaccine trial

Cobra Biologics to manufacture plasmids for COVID-19 vaccine trial

5 Oct 2020

Scancell’s DNA vaccine could provide long-lasting immunity against COVID-19 by generating protection against this and new strains of coronavirus.

Read more 
Festival of Pharma empowers GVK BIO to meet with smaller companies that don’t normally attend events

Festival of Pharma empowers GVK BIO to meet with smaller companies that don’t normally attend events

1 Oct 2020

Ahead of the world’s largest ever virtual pharma expo – the CPhI Festival of Pharma – Informa Markets spoke with Ramesh Subramanian, Chief Commercial Officer at GVK BIO on how they are preparing for the event.

Read more 
Novel customizable and flexible single-use assembly solution

Novel customizable and flexible single-use assembly solution

29 Sep 2020

Hugh Purity New England's solution can utilize other vendors' components and can be implemented directly into any process.

Read more 
New preventative nasal spray treatment could protect from COVID-19 infection

New preventative nasal spray treatment could protect from COVID-19 infection

28 Sep 2020

Novel therapy developed by Australian biotech company, Ena Respiratory, shown to significantly reduce COVID-19 virus levels in the nose and throat.

Read more 
Alvotech and DKSH extend biosimilar partnership in Asia

Alvotech and DKSH extend biosimilar partnership in Asia

22 Sep 2020

The companies will commercialize six new biosimilar candidates addressing multiple therapeutic areas.

Read more